Clinical site monitoring for FDA-funded human subject research studies ucsf, SAN francisco CA
Ended Awarded Last action
- Contract number
- 75F40121F19021
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,392
Award facts
- Contract value 100% obligated
- $1,391.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Terminate for Convenience | -$19,276 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $20,668 |
About this award
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to The Emmes Company LLC, a for-profit limited liability company, to provide clinical site monitoring services for FDA-funded human subject research studies. The potential value of the contract is $1,391.98 and the period of performance ends on December 5, 2023. The Emmes Company is a global clinical research organization that provides biostatistical, epidemiological, data management, and logistical support services for clinical and laboratory research programs on behalf of government agencies and commercial partners. The company has extensive experience supporting clinical trials and research networks across multiple National Institutes of Health (NIH) institutes, including the National Institute on Drug Abuse, National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Human Genome Research Institute. This contract is not set aside for any specific business types.
Quick answers
Who was awarded contract 75F40121F19021?
75F40121F19021 was awarded to The Emmes Company, LLC by Food and Drug Administration (Department of Health and Human Services) on September 16, 2021.
How much is contract 75F40121F19021 worth?
The government has obligated $1,392 on 75F40121F19021.
Is contract 75F40121F19021 an order under another contract?
Yes. 75F40121F19021 is a delivery order under HHSF223201710031I, an indefinite delivery contract.
Was contract 75F40121F19021 competed?
The extent of competition for 75F40121F19021 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award